UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045737
Receipt number R000051351
Scientific Title An exploratory study of factors associated with the development of post-intensive care syndrome
Date of disclosure of the study information 2021/10/12
Last modified on 2025/04/14 17:15:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study of factors associated with the development of post-intensive care syndrome

Acronym

An exploratory study of factors associated with the development of post-intensive care syndrome

Scientific Title

An exploratory study of factors associated with the development of post-intensive care syndrome

Scientific Title:Acronym

An exploratory study of factors associated with the development of post-intensive care syndrome

Region

Japan


Condition

Condition

Critical Care Medicine

Classification by specialty

Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the actual condition of sleep disorders in patients after leaving the ICU and the relationship between the onset of PICS and the subsequent outcome.

Basic objectives2

Others

Basic objectives -Others

To clarify the actual condition of sleep disorders in patients after leaving the ICU and the relationship between the onset of PICS and the subsequent outcome.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of PICS 6 months after discharge of patients admitted to the ICU

Key secondary outcomes

Sleep status (objective data by brain wave measurement type sleep measurement, subjective data by questionnaire)
Onset and duration of delirium (days)
Length of stay in ICU
Number of days of hospitalization after leaving the ICU
Length of hospitalization
Scores for each scale related to physical function, depression, traumatic stress symptoms, physical symptoms, fatigue, subjective insomnia severity, and cognitive function.
Outcome after 6 months, outcome after 2 years (re-hospitalization and death)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients over 20 years of age at the time of consent
Patients who can communicate in Japanese
Patients who entered the ICU and stayed for 72 hours or more
Patients who received sufficient explanation before participating in this study, and after sufficient understanding, obtained the voluntary written consent of the patient (or a substitute if necessary).
Patients who meet all of the above are targeted.

Key exclusion criteria

Patients with advanced cognitive dysfunction
Patients with brain injury (anaerobic brain injury, stroke, traumatic brain injury) before and during ICU admission
Patients after organ transplantation
Patients expected to die within 3 months of discharge
Patients with unstable mental illness
Other patients who the principal investigator deems inappropriate as a subject

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Nomura

Organization

Tokyo Women's Medical university

Division name

Department of Intensive Care Medicine

Zip code

162-8666

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

tnomura@twmu.ac.jp


Public contact

Name of contact person

1st name Nobuo
Middle name
Last name Sato

Organization

Tokyo Women's Medical University

Division name

Department of Intensive Care Medicine

Zip code

162-8666

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Homepage URL


Email

nsato-nst@umin.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Women's Medical University Ethics Review Board

Address

8-1, Kawada-cho, Shinjuku-ku, Tokyo

Tel

03-3353-8111

Email

rinri.bm@twmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 12 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

64

Results

The number (percentage) of patients with moderate or severe insomnia with an ISI score of 15 or higher was 1 (2.4%), 18 (44%), and 4 (9.8%) before, after, and 6 months after ICU admission, ICU discharge, and hospital discharge, respectively.

Results date posted

2024 Year 04 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

Not appliciate

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 08 Month 11 Day

Date of IRB

2021 Year 10 Month 22 Day

Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not applicable


Management information

Registered date

2021 Year 10 Month 12 Day

Last modified on

2025 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051351